![](https://endpts.com/wp-content/uploads/2020/08/Giovanni-Caforio-Getty-scaled.jpg)
Giovanni Caforio (Photographer: Christopher Goodney/Bloomberg via Getty Images)
#ASCO21: Bristol Myers takes home the win in 1st late-stage study for LAG-3 pathway, setting up a US filing
When Bristol Myers Squibb dropped winning late-stage data for its anti-LAG-3 drug in March, the results offered new hope for an immune checkpoint pathway that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.